Back to search

Article

Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory Benefit

2025-06-20

Abstract excerpt

<title>Abstract</title> <p> Azithromycin is often prescribed unnecessarily for respiratory infections, many of which are viral. During the COVID-19 pandemic, its use was widespread, in part due to alleged therapeutic benefits, which have since been disproven. Here, we sought to understand the impact of azithromycin exposure on the respiratory microbiome, antimicrobial resistome, and host immune response in a pro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c756dfc8-3057-53dd-8d68-6a526f227e83
DOI
10.21203/rs.3.rs-6875205/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory BenefitDOI 10.21203/rs.3.rs-6875205/v1
Select a neighboring publication to make it the new centre.